Jingbao Liu

Title: Innovations by Jingbao Liu in Coronavirus Treatment

Introduction

Jingbao Liu is an accomplished inventor based in Castro Valley, CA (US). He has made significant contributions to the field of medical research, particularly in the area of viral infections. His innovative work focuses on developing compositions that can prevent or treat infections, including those caused by coronaviruses.

Latest Patents

Jingbao Liu holds a patent for "Compositions for preventing or treating coronavirus infections." This patent describes chimeric proteins that include a target-binding moiety derived from the extracellular binding domain (EBD) of an angiotensin-converting enzyme 2 (ACE2) protein. These proteins are designed to specifically bind to the S protein of the virus. The compositions comprising these chimeric proteins are intended to be useful in preventing or treating viral infections in individuals, particularly those caused by coronaviruses. He has 1 patent to his name.

Career Highlights

Jingbao Liu is associated with Invisishield Technologies Ltd., where he continues to work on innovative solutions for viral infections. His research has the potential to impact public health significantly, especially in the context of emerging viral threats.

Collaborations

Jingbao Liu collaborates with Hongbing Zhang, contributing to the advancement of research in the field of virology. Their combined efforts aim to enhance the understanding and treatment of viral infections.

Conclusion

Jingbao Liu's work exemplifies the importance of innovation in addressing global health challenges. His contributions to the development of antiviral compositions are crucial in the fight against coronavirus infections.